title: Phase II evaluation of doxorubicin plus amiodarone in advanced hepatocarcinoma.
authors.forename: B
authors.initials: B
authors.lastname: Chauffert
authors.forename: J F
authors.initials: JF
authors.lastname: Seitz
authors.forename: L
authors.initials: L
authors.lastname: Bedenne
authors.forename: P
authors.initials: P
authors.lastname: Renard
authors.forename: T
authors.initials: T
authors.lastname: Conroy
authors.forename: P
authors.initials: P
authors.lastname: Rougier
mesh_terms: D000328:Adult; D000368:Aged; D000638:Amiodarone / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy*; D004317:Doxorubicin / Q000627:therapeutic use*; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy*; D008875:Middle Aged
chemical_list: D004317:Doxorubicin; D000638:Amiodarone